SCHEMBL429687

SCHEMBL429687

O=C(Cl)c1cccnc1F

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 2/20 0.68
ALDH1A1 P00352 2/20 0.52
ALOX15 P16050 2/20 0.52
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KDM4E B2RXH2 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
MAPT P10636 2/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
BLM P54132 1/20 0.44
AGER Q15109 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
P2RX7 Q99572 1/20 0.42
DHODH Q02127 1/20 0.40
KMT2A Q03164 2/20 0.39
PARP1 P09874 1/20 0.39
SLC18A3 Q16572 1/20 0.39
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6224044 0.93 NAPRT (0.82) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
SCHEMBL28705950 0.85 NAPRT (0.70) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
SCHEMBL27612856 0.83 NAPRT (0.73) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
SCHEMBL19280924 0.81 NAPRT (1.00) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
SCHEMBL229352 0.81 NAPRT (1.00) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
SCHEMBL29574424 0.81 NAPRT (1.00) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
SCHEMBL447126 0.79 NAPRT (0.68) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
SCHEMBL31078773 0.79 NAPRT (0.68) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
Hydrochloric Acid SCHEMBL4407488 0.79 NAPRT (0.96) NAPRTALDH1A1ALOX15LMNASMN1; SMN2
SCHEMBL1811012 0.79 NAPRT (0.68) NAPRTALDH1A1ALOX15LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103524407-B One group of 2-fluoro-3-pyridine carbamoyl compound QINGDAO AGRICULTURAL UNIVERSITY (CN) 2015-12-02 CN claimed
CN-103242308-B 2-fluoro pyridine derivatives, as well as preparation method and application thereof UNIV QINGDAO AGRICULTURAL 2015-07-01 CN claimed
CN-103524407-A 2-fluorine-3-pyridine formyl compounds UNIV QINGDAO AGRICULTURAL 2014-01-22 CN claimed
CN-103242308-A 2-fluoro pyridine derivatives, as well as preparation method and application thereof UNIV QINGDAO AGRICULTURAL 2013-08-14 CN claimed
CN-119930720-A Application of spinosyn derivative as pesticide 利民化学有限责任公司 2025-05-06 CN disclosed
CN-119823033-A Synthesis method of 2-fluoropyridine-5-formyl chloride 湖南化工研究院有限公司 2025-04-15 CN disclosed
CN-115785180-B Spinosyn derivative as pesticide, and preparation method and application thereof 利民化学有限责任公司 2025-03-07 CN disclosed
CN-118271285-A Azetidine-containing amide derivative, preparation method and application thereof 贵州大学 2024-07-02 CN disclosed
CN-117510338-A Natural naphthoquinone derivative and preparation method and application thereof 贵州大学 2024-02-06 CN disclosed
CN-116874441-A Flexible aryl formamide derivative containing 1,2, 4-oxadiazole as well as preparation method and application thereof 贵州大学 2023-10-13 CN disclosed
CN-115785180-A Spinosad derivative as pesticide and preparation method and application thereof 利民化学有限责任公司 2023-03-14 CN disclosed
CN-114736170-A Aryl amide compound containing thia (oxazoline) and preparation method and application thereof in preparing bactericide 贵州大学 2022-07-12 CN disclosed
US-20030203922-A1 Substituted amine derivatives and methods of use AMGEN INC. 2003-10-30 US disclosed
US-20030195230-A1 Substituted amine derivatives and methods of use AMGEN INC. 2003-10-16 US disclosed
US-20030134836-A1 Substituted arylamine derivatives and methods of use AMGEN INC. 2003-07-17 US disclosed
US-20030125339-A1 Substituted alkylamine derivatives and methods of use AMGEN INC. 2003-07-03 US disclosed
US-20020147198-A1 Substituted arylamine derivatives and methods of use AMGEN INC. 2002-10-10 US disclosed
WO-2002068406-A2 SUBSTITUTED AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF ANGIOGENESIS AMGEN INC. (US) 2002-09-06 WO disclosed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 WO disclosed
WO-2002055501-A2 N-PYRIDYL CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AMGEN INC (US) 2002-07-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125339-A1 Substituted alkylamine derivatives and methods of use AADAC, NAT1, PIGO NAPRT 213/4885ALDH1A1 261/4885ALOX15 229/4885
US-20030134836-A1 Substituted arylamine derivatives and methods of use NAT1, AADAC, AHR NAPRT 113/4885ALDH1A1 178/4885ALOX15 588/4885
US-20030203922-A1 Substituted amine derivatives and methods of use MAOB, HNMT, FLT4 NAPRT 127/4885ALDH1A1 192/4885ALOX15 730/4885
US-20020147198-A1 Substituted arylamine derivatives and methods of use NAT1, AADAC, AHR NAPRT 113/4885ALDH1A1 178/4885ALOX15 588/4885
US-20030195230-A1 Substituted amine derivatives and methods of use MAOB, HNMT, FLT4 NAPRT 127/4885ALDH1A1 192/4885ALOX15 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.